The FDA and Sanofi-Aventis, the makers of the arterial fibrillation drug Multaq, have issued a warning for potential liver damage in patients taking the medication.
Patients taking Multaq are should immediately report any symptoms suggestive of liver dysfunction to their physician. Symptoms of liver dysfunction include:
- Loss of appetite
- Unusual fatigue
- Right upper stomach area pain
- Yellowing of the skin/eyes
- Unusual darkening of urine